PathScan? Phospho-p53 (Ser15) Sandwich ELISA Antibody Pair

• 产品编号：CST-7846S      品牌：CST       原厂货号：7846S
• 产品分类：ELISA及其它免疫分析 > ELISA > ELISA检测抗体对
• 应用分类：

其它组分：

描述：

关于该抗体对的特异性和敏感性，请参阅相应的PathScan® Sandwich ELISA试剂盒。注：经过内部测试，该抗体对能够检测指定物种的蛋白，但是也可以检测来自其他物种的同源蛋白。相对于CST的PathScan® Phospho-p53 (Ser15) Sandwich ELISA Kit #7365，PathScan® Phospho-p53 (Ser15) Sandwich ELISA Antibody Pair提供了一个经济的选择。我们提供了捕获和检测抗体(100X储备液)和HRP-结合的二级抗体(1000X储备液)，针对4 x 96 孔ELISAs的试剂也非常充分。p53 Capture Antibody在含有PBS的96孔板中包被过夜。封闭后加入Phospho-p53 (Ser15) Detection Antibody和 anti-Mouse IgG, HRP 偶联抗体，随后加入细胞裂解液。加入HRP底物(TMB)进行显色。显色过程中吸光度的强度和丝氨酸（15位）磷酸化p53蛋白的量成正比。该试剂盒中的抗体具有特异性的固定组成。p53肿瘤抑制蛋白在细胞响应DNA损伤和其它基因组异常的过程中发挥重要作用。p53的激活能够引起细胞周期捕获和DNA修复或细胞凋亡(1)。离体或者在体情况下，p53可以在多个位点被几个蛋白激酶进行磷酸化(2,3)。DNA损伤能够诱导p53的第15位和20位丝氨酸磷酸化，导致p53和其负调节子-癌蛋白MDM2的相互作用减弱(4)。MDM2通过靶向p53促进其泛素化和蛋白酶体降解抑制其累积。P53的第15位和37位丝氨酸可以被ATM，ATR，和DNA-PK磷酸化(5,6)。P53的磷酸化削弱了MDM2的结合，从而促进了它的激活和累积以响应DNA损伤(4,7)。Chk2和Chk1能够磷酸化p53的第20位丝氨酸，增强其四聚化、稳定性和活性(8,9)。p53的第392位丝氨酸可以发生在体磷酸化(10,11)和CAK介导的离体磷酸化(11)。人类肿瘤中p53的第392位丝氨酸磷酸化增加(12)且有报道认为该过程能够影响生长抑制剂的功能、DNA结合和p53的转录激活(10,13,14)。P53的第6位和9位丝氨酸离体或者在体均可以被CK1δ和CK1ε磷酸化(13,15)。P53的第46位丝氨酸磷酸化能够调节p53诱导细胞凋亡的能力(16)。p300和CBP乙酰转移酶能够介导p53的乙酰化。去乙酰化抑制可以阻止MDM2招募p19 (ARF)介导的HDAC1复合体从而稳定p53。乙酰化似乎对于应激反应中p53蛋白的累积起着正向的作用(17)。DNA损伤后，人类p53的第382位赖氨酸(在小鼠为379位赖氨酸)发生在体乙酰化，促进p53-DNA的结合(18)。P53通过与SIRT1蛋白(一种参与细胞衰老和DNA损伤应激的去乙酰酶)相互作用发生去乙酰化(19)。

1. Levine, A.J. (1997) Cell 88, 323-31.
2. Meek, D.W. (1994) Semin Cancer Biol 5, 203-10.
3. Milczarek, G.J. et al. (1997) Life Sci 60, 1-11.
4. Shieh, S.Y. et al. (1997) Cell 91, 325-34.
5. Chehab, N.H. et al. (1999) Proc Natl Acad Sci U S A 96, 13777-82.
6. Honda, R. et al. (1997) FEBS Lett 420, 25-7.
7. Tibbetts, R.S. et al. (1999) Genes Dev 13, 152-7.
8. Shieh, S.Y. et al. (1999) EMBO J 18, 1815-23.
9. Hirao, A. et al. (2000) Science 287, 1824-7.
10. Hao, M. et al. (1996) J Biol Chem 271, 29380-5.
11. Lu, H. et al. (1997) Mol Cell Biol 17, 5923-34.
12. Ullrich, S.J. et al. (1993) Proc Natl Acad Sci U S A 90, 5954-8.
13. Kohn, K.W. (1999) Mol Biol Cell 10, 2703-34.
14. Lohrum, M. and Scheidtmann, K.H. (1996) Oncogene 13, 2527-39.
15. Knippschild, U. et al. (1997) Oncogene 15, 1727-36.
16. Oda, K. et al. (2000) Cell 102, 849-62.
17. Ito, A. et al. (2001) EMBO J 20, 1331-40.
18. Sakaguchi, K. et al. (1998) Genes Dev 12, 2831-41.
19. Solomon, J.M. et al. (2006) Mol Cell Biol 26, 28-38.

原厂资料：

Specificity / Sensitivity

For Antibody Pair specificity and sensitivity, please refer to the corresponding PathScan® Sandwich ELISA Kit. Note: This antibody pair detects proteins from the indicated species, as determined through in-house testing, but may also detect homologous proteins from other species.

Description

CST's PathScan® Phospho-p53 (Ser15) Sandwich ELISA Antibody Pair is being offered as an economical alternative to our PathScan® Phospho-p53 (Ser15) Sandwich ELISA Kit #7365. Capture and Detection antibodies (100X stocks) and HRP-conjugated secondary antibody (1000X stock) are supplied. Sufficient reagents are supplied for 4 x 96 well ELISAs. The p53 Capture Antibody is coated in PBS overnight in a 96 well microplate. After blocking, cell lysates are added followed by a Phospho-p53 (Ser15) Detection Antibody and anti-Mouse IgG, HRP conjugated antibody. HRP substrate, TMB, is added for color development. The magnitude of the absorbance for this developed color is proportional to the quantity of phospho-p53 (Ser15) protein. 
 *Antibodies in this kit are custom formulations specific to the kit.

Background

The p53 tumor suppressor protein plays a major role in cellular response to DNA damage and other genomic aberrations. Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis (1). p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in vitro (2,3). DNA damage induces phosphorylation of p53 at Ser15 and Ser20 and leads to a reduced interaction between p53 and its negative regulator, the oncoprotein MDM2 (4). MDM2 inhibits p53 accumulation by targeting it for ubiquitination and proteasomal degradation (5,6). p53 can be phosphorylated by ATM, ATR, and DNA-PK at Ser15 and Ser37. Phosphorylation impairs the ability of MDM2 to bind p53, promoting both the accumulation and activation of p53 in response to DNA damage (4,7). Chk2 and Chk1 can phosphorylate p53 at Ser20, enhancing its tetramerization, stability, and activity (8,9). p53 is phosphorylated at Ser392 in vivo (10,11) and by CAK in vitro (11). Phosphorylation of p53 at Ser392 is increased in human tumors (12) and has been reported to influence the growth suppressor function, DNA binding, and transcriptional activation of p53 (10,13,14). p53 is phosphorylated at Ser6 and Ser9 by CK1δ and CK1ε both in vitro and in vivo (13,15). Phosphorylation of p53 at Ser46 regulates the ability of p53 to induce apoptosis (16). Acetylation of p53 is mediated by p300 and CBP acetyltransferases. Inhibition of deacetylation suppressing MDM2 from recruiting HDAC1 complex by p19 (ARF) stabilizes p53. Acetylation appears to play a positive role in the accumulation of p53 protein in stress response (17). Following DNA damage, human p53 becomes acetylated at Lys382 (Lys379 in mouse) in vivo to enhance p53-DNA binding (18). Deacetylation of p53 occurs through interaction with the SIRT1 protein, a deacetylase that may be involved in cellular aging and the DNA damage response (19). 

1. Levine, A.J. (1997) Cell 88, 323-31.
2. Meek, D.W. (1994) Semin Cancer Biol 5, 203-10.
3. Milczarek, G.J. et al. (1997) Life Sci 60, 1-11.
4. Shieh, S.Y. et al. (1997) Cell 91, 325-34.
5. Chehab, N.H. et al. (1999) Proc Natl Acad Sci U S A 96, 13777-82.
6. Honda, R. et al. (1997) FEBS Lett 420, 25-7.
7. Tibbetts, R.S. et al. (1999) Genes Dev 13, 152-7.
8. Shieh, S.Y. et al. (1999) EMBO J 18, 1815-23.
9. Hirao, A. et al. (2000) Science 287, 1824-7.
10. Hao, M. et al. (1996) J Biol Chem 271, 29380-5.
11. Lu, H. et al. (1997) Mol Cell Biol 17, 5923-34.
12. Ullrich, S.J. et al. (1993) Proc Natl Acad Sci U S A 90, 5954-8.
13. Kohn, K.W. (1999) Mol Biol Cell 10, 2703-34.
14. Lohrum, M. and Scheidtmann, K.H. (1996) Oncogene 13, 2527-39.
15. Knippschild, U. et al. (1997) Oncogene 15, 1727-36.
16. Oda, K. et al. (2000) Cell 102, 849-62.
17. Ito, A. et al. (2001) EMBO J 20, 1331-40.
18. Sakaguchi, K. et al. (1998) Genes Dev 12, 2831-41.
19. Solomon, J.M. et al. (2006) Mol Cell Biol 26, 28-38.

注意事项：

Storage: Capture and Detection Antibodies are stored at 4ºC.
Anti-Mouse IgG, HRP-Linked Antibody is stored at -20ºC.